Group: 2025 Methods Summit

Brandy Farrar, PhD, MS has over 18 years of experience as a qualitative methodologist whose primary expertise is in identifying evidence-based practices for improving health. Dr. Farrar routinely deploys a variety of methodologies to engage interested parties in designing, implementing and evaluating policies and programs. Examples of Dr. Farrar’s current and recent work include using human…

Sarita Edwards is the CEO & President at the E.WE Foundation, a global healthcare advocacy organization for families impacted by Trisomy 18 and other rare diseases. Sarita began her advocacy and public policy efforts after receiving a rare genetic diagnosis for her unborn son. Sarita is recognized as a world’s top patient expert and social…

Bridget Doherty, MPH, MS, is a strategic policy, research, and communications professional with extensive experience in pharmaceuticals, medical devices, and healthcare publishing. Currently serving as the Director of Access and Policy Research at Johnson & Johnson Innovative Medicine, she develops and executes impactful policy research and scientific engagement plans aimed at developing an evidence-based understanding…

For nearly two decades, Dr. Spangler, IVI Chief Executive Officer, has worked in the professional health policy and public health sector with pharmaceutical and non-profit organizations. Dr. Spangler joins IVI from his most recent role as Executive Medical Director and Director and Head of Global HTA Policy Strategy & Engagement for Amgen, Inc. Dr. Spangler…

Ilisa Halpern Paul is a senior policy advisor at Venable LLP in the firm’s Washington, DC office. Ilisa co-leads the firm’s Federal Health Policy team, drawing on more than 30 years of recorded success in helping established and start-up healthcare companies, health and hospital systems, provider associations, and nonprofit patient advocacy organizations advance their legislative,…